The Luxe Journal · Neuromodulators

Botox vs. Daxxify: What's the Difference and Which Wrinkle Relaxer Is Right for You?

Botox and Daxxify both relax expression lines but work differently. Compare onset, duration, and treatment areas to find the right fit for you.

The short answer

Botox and Daxxify are both neuromodulators that temporarily relax the facial muscles behind expression lines, but they are not the same product. Daxxify® (daxibotulinumtoxinA-lanm) is FDA-approved for frown lines and formulated to last longer between sessions, while Botox® Cosmetic (onabotulinumtoxinA) has FDA approval for frown lines, forehead lines, and crow's feet. Choosing between them depends on your goals and how often you want to schedule treatment — a conversation best had during a consultation for Daxxify neuromodulator treatments in Burtonsville.

If you've searched for a wrinkle relaxer near Burtonsville, Maryland, you've likely come across both Botox and Daxxify — and wondered whether they're the same thing or genuinely different treatments. They belong to the same drug class, but they're distinct, FDA-regulated products with different formulations, different approved uses, and different dosing. Understanding those differences makes it easier to have an informed conversation at your consultation, whatever you ultimately choose.

What Are Neuromodulators?

Neuromodulators are injectable treatments that temporarily block nerve signals to targeted facial muscles, reducing the repeated muscle contractions that create expression lines over time — the lines that form from years of frowning, squinting, or raising the brows. They don't add volume or change facial structure; they simply relax the muscle activity causing a specific line to soften. Botox, Daxxify, Dysport, and Xeomin are all neuromodulators, each built on a form of botulinum toxin but manufactured and dosed differently.

What Is Botox Cosmetic?

Botox Cosmetic (onabotulinumtoxinA) is a botulinum toxin type A injectable that has been used cosmetically since the early 2000s. It's FDA-approved for the temporary improvement of moderate to severe glabellar lines (frown lines, sometimes called "11s"), lateral canthal lines (crow's feet), and forehead lines associated with frontalis muscle activity in adults. Its long history of use means there's extensive published dosing guidance across these and other facial areas.

What Is Daxxify?

Daxxify (daxibotulinumtoxinA-lanm) is a newer botulinum toxin type A injectable, FDA-approved for the temporary improvement of moderate to severe glabellar lines in adults. Its formulation uses a proprietary peptide in place of the human serum albumin found in some other neuromodulators, and clinical studies submitted to the FDA showed effects lasting notably longer than what's typically reported with Botox for the same indication. Many providers, including Luxe By Afsaneh, also use Daxxify off-label for other facial areas based on clinical judgment and patient goals.

How Botox and Daxxify Work

Both products work the same basic way: they're injected directly into a targeted muscle, where they temporarily interrupt the nerve signal that tells that muscle to contract. Less muscle movement means the overlying skin creases less, allowing the line to soften over the following days to weeks. Neither product is a filler, and neither adds volume — they address the muscle movement causing a dynamic wrinkle, not static skin laxity or lost volume.

Key Differences Between Botox and Daxxify

Botox CosmeticDaxxify
Active ingredientOnabotulinumtoxinADaxibotulinumtoxinA-lanm
FDA-approved cosmetic usesFrown lines, forehead lines, crow's feetFrown lines
Typical onsetAround 3–7 days, full effect by 2 weeksAs early as 1–2 days
Typical durationAround 3–4 monthsOften 5–6 months, sometimes longer
FDA-approved glabellar dose20 units40 units
Formulation stabilizerHuman serum albuminProprietary peptide (albumin-free)

Individual results vary, and these figures reflect general clinical data rather than a guarantee for any specific person.

Botox vs. Daxxify for Forehead Concerns

Forehead lines are an FDA-approved indication for Botox Cosmetic, meaning there's an established, studied dosing protocol for this area. Daxxify does not currently carry FDA approval for forehead lines — using it there is considered off-label, which simply means the treatment is used outside its approved indication based on a provider's clinical judgment, not that it's unsafe or unusual in aesthetic practice. Either approach should be discussed with your provider based on your forehead's muscle activity and your goals.

Botox vs. Daxxify for Frown Lines (Glabellar Lines / "11s")

Frown lines between the brows are the one area where both products carry FDA approval, which is why most direct comparison data focuses here. Clinical trial data submitted to the FDA showed the majority of participants achieved none or minimal frown lines within about a month of treatment with either product, with Daxxify's effect generally persisting longer in follow-up assessments.

Botox vs. Daxxify for Crow's Feet

Crow's feet, the fine lines that fan out from the outer corners of the eyes, are an FDA-approved indication for Botox Cosmetic. Daxxify is not currently FDA-approved for this area, so its use here is off-label. Because the muscle around the eye is thin and close to the skin surface, providers typically use conservative dosing regardless of which product is chosen.

Are Botox and Daxxify Units Interchangeable?

No. This is one of the most important distinctions between the two products. The FDA-approved dose of Daxxify for frown lines is 40 units, compared to the FDA-approved dose of Botox Cosmetic for the same area, which is 20 units. A "unit" of one product is not equivalent to a "unit" of the other, so dosing cannot be converted one-to-one between them. Your provider will determine an appropriate dose for the specific product used, not simply substitute one for the other at the same number.

Who Is a Candidate for a Neuromodulator?

Good candidates are generally healthy adults bothered by dynamic wrinkles — lines that appear or deepen with facial movement — who understand that results are temporary and require maintenance. Neuromodulators aren't appropriate for everyone; pregnancy, breastfeeding, certain neuromuscular conditions, and known allergy to the product's ingredients are reasons a provider may advise against treatment. A consultation is the appropriate place to review your health history and determine candidacy — not every person is automatically a candidate, and no provider should suggest otherwise.

Side Effects and Risks to Know

Both Botox and Daxxify carry similar general risks, since they belong to the same drug class. Reported effects can include injection-site pain, bruising, redness, or swelling; headache; and, less commonly, temporary eyelid or brow drooping if the product spreads beyond the intended muscle. These effects are generally temporary. Serious risks are rare but possible with any botulinum toxin product, which is why treatment should always be performed by a qualified, trained provider who can discuss your individual risk profile.

What to Expect at a Consultation

A consultation is where your provider reviews your goals, examines your facial muscle movement, discusses your health history, and recommends a treatment plan — including which product may fit your situation and an honest estimate of units needed. At Luxe By Afsaneh, treatment is performed by an experienced Nurse Practitioner with a critical care and neurosurgical background, using an education-first approach and conservative dosing. You can review neuromodulator and Daxxify pricing or explore the full med spa services menu before booking.

Which One Is Right for You?

Neither product is universally "better" — they're different tools with different approved uses, timelines, and dosing. If you're specifically focused on forehead lines or crow's feet, Botox's broader FDA approval may be a more studied fit for those areas. If longer-lasting frown-line results with fewer touch-ups appeal to you, Daxxify's approved indication and longer reported duration may be worth discussing — our breakdown of how long Botox and Daxxify each last covers this in more detail. The most reliable way to decide is a consultation where your muscle activity, goals, and history are reviewed individually.

FAQ

Questions before you book?

Clear answers, realistic expectations, and no-pressure guidance.

No. Daxxify and Botox are both botulinum toxin type A products, but they're manufactured differently, dosed differently, and FDA-approved for different indications. They should not be considered interchangeable versions of the same treatment.

No. "Botox" refers specifically to the brand Botox Cosmetic (onabotulinumtoxinA). Daxxify is a separate, distinct product (daxibotulinumtoxinA-lanm) made by a different manufacturer with its own formulation and FDA approval.

Clinical trial data submitted to the FDA for the frown-line indication showed Daxxify's effects generally lasting longer than what's typically reported with Botox — often around five to six months compared to roughly three to four months — though individual results vary and neither duration is guaranteed.

Daxxify has been reported to show initial effects within one to two days, while Botox typically shows visible improvement within three to seven days, with full effect by about two weeks. Onset can vary by individual and treatment area.

Daxxify is not currently FDA-approved for forehead lines; its approved indication is frown lines. Some providers use it off-label for the forehead based on clinical experience, but this falls outside its approved use.

Daxxify is not currently FDA-approved for crow's feet. Botox Cosmetic is FDA-approved for this area. Off-label use of Daxxify for crow's feet is a decision made between provider and patient outside the approved indication.

Daxxify is FDA-approved for the temporary improvement of moderate to severe glabellar lines (frown lines) in adults. Any other use, including forehead lines, crow's feet, or masseter/jaw treatment, is considered off-label.

No. The FDA-approved dose of Daxxify for frown lines is 40 units, while the FDA-approved dose of Botox Cosmetic for the same area is 20 units. Units between the two products are not interchangeable or directly comparable.

Most people describe the injections as a brief pinching sensation rather than significant pain. Treatment takes only a few minutes, and no anesthesia is typically required.

No significant downtime is expected with either product. Most people resume normal activities immediately, though avoiding strenuous exercise and lying flat for a few hours after treatment is commonly recommended.

Initial changes may appear within a few days, with full results developing over one to two weeks, depending on the product and treatment area.

The right choice depends on the area you want treated, whether that area has FDA approval for the product being considered, how often you're willing to schedule touch-ups, and your provider's clinical recommendation after reviewing your muscle activity and goals.

Every treatment at Luxe By Afsaneh Medical Aesthetics is personally performed by Afsaneh, an experienced Nurse Practitioner with a critical care and neurosurgical nursing background.

Luxe By Afsaneh Medical Aesthetics offers Daxxify® neuromodulator treatments by appointment in Burtonsville, Maryland, also serving Silver Spring, Columbia, Laurel, Olney, and surrounding communities. You can view [Daxxify treatment details and pricing](https://luxeburtonsvillemedspa.com/services/botox-daxxify-burtonsville-md/index.html) or [contact the clinic to book a consultation](https://luxeburtonsvillemedspa.com/contact/index.html).

Appointment Only

Discuss your goals with Afsaneh

Every treatment plan starts with an unhurried, education-first consultation in Burtonsville, Maryland.

Call/Text 202-766-3001